Recent updates on drug resistance in Mycobacterium tuberculosis
Tuberculosis (TB) along with acquired immune deficiency syndrome and malaria rank
among the top three fatal infectious diseases which pose threat to global public health …
among the top three fatal infectious diseases which pose threat to global public health …
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are generally
thought to have high mortality rates. However, many cases can be treated with the right …
thought to have high mortality rates. However, many cases can be treated with the right …
[BOOK][B] WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-resistant tuberculosis treatment, 2022 update
World Health Organization - 2022 - books.google.com
The WHO Consolidated Guidelines on Tuberculosis (TB), Module 4: Treatment-Drug-
Resistant Tuberculosis Treatment 2022 update informs health care professionals in Member …
Resistant Tuberculosis Treatment 2022 update informs health care professionals in Member …
[BOOK][B] WHO consolidated guidelines on drug-resistant tuberculosis treatment
World Health Organization - 2019 - apps.who.int
Executive summary Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult
to treat than drug-susceptible ones, and threaten global progress towards the targets set by …
to treat than drug-susceptible ones, and threaten global progress towards the targets set by …
[BOOK][B] Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008
World Health Organization - 2008 - apps.who.int
The emergence in 2006 of extensively drug-resistant strains of tuberculosis, especially in
countries with a high prevalence of human immunodeficiency virus, are serious threats to …
countries with a high prevalence of human immunodeficiency virus, are serious threats to …
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients
SD Ahuja, D Ashkin, M Avendano, R Banerjee… - 2012 - journals.plos.org
Background Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic,
expensive, and has generally poor outcomes. We undertook an individual patient data meta …
expensive, and has generally poor outcomes. We undertook an individual patient data meta …
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Drug resistance in tuberculosis (TB) is a particular problem because the lengthy therapy of
at least 6 months makes patient compliance very difficult, which frequently creates drug …
at least 6 months makes patient compliance very difficult, which frequently creates drug …
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
V Dartois - Nature Reviews Microbiology, 2014 - nature.com
For the successful treatment of pulmonary tuberculosis, drugs need to penetrate complex
lung lesions and permeate the mycobacterial cell wall in order to reach their intracellular …
lung lesions and permeate the mycobacterial cell wall in order to reach their intracellular …
Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis
Background Treatment outcomes for multidrug-resistant Mycobacterium Tuberculosis
(MDRTB) are generally poor compared to drug sensitive disease. We sought to estimate …
(MDRTB) are generally poor compared to drug sensitive disease. We sought to estimate …
[CITATION][C] WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D Falzon, E Jaramillo, HJ Schünemann, M Arentz… - 2011 - Eur Respiratory Soc